Wells Fargo analyst John Kilichowski lowered the firm’s price target on National Health Investors (NHI) to $76 from $80 and keeps an Equal Weight rating on the shares. The firm is adjusting price targets across its Healthcare and Net Leasing REIT coverage based on its AFFO yield spread regression analyses and updated NAVs.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NHI:
- National Health Investors price target lowered to $91 from $92 at BofA
- Navigating Risks: National Health Investors’ Potential Exposure in Forward Sale Agreements
- National Health Investors Reports Q3 2024 Results
- National Health Investors Founder W. Andrew Adams Retires
- National Health Investors Highlights Strategic Growth Plans